Literature DB >> 11305872

Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.

J Takahashi1, J Tanaka, K Arai, N Funata, T Hattori, T Fukuda, H Fujigasaki, T Uchihara.   

Abstract

Recruitment of polyglutamine-containing proteins into nuclear inclusions (NIs) was investigated in neuronal intranuclear hyaline inclusion disease (NIHID). Some polyglutamine-containing proteins, ataxin-2, ataxin-3, and TATA box binding protein (TBP), as well as unidentified proteins with expanded polyglutamine tracts were recruited into NIs with different frequencies. Ataxin-3 was incorporated into most of the NIs and disappeared from its normal cytoplasmic localization, whereas only a small fraction of NIs contained ataxin-2 and TBP. The consistent presence of ataxin-3 in NIs could reflect a biological feature of wild-type ataxin-3, which is translocated into the nucleus under pathological conditions and participates in the formation of aggregates. Ataxin-2 also accumulated in the nucleus, but was not necessarily incorporated into NIs, suggesting that transport of these cytoplasmic proteins into the nucleus and their recruitment into NIs are not wholly explained by an interaction with a polyglutamine stretch and must be regulated in part by other mechanisms. The prevalence of ubiquitin-immunopositive NIs was inversely correlated to neuronal loss in all cases examined. This correlation could be explained if NI formation is a protective mechanism involving the ubiquitin-proteasome pathway. This hypothesis is supported by the finding that the polyglutamine epitope in the center of NIs was surrounded by ubiquitin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11305872     DOI: 10.1093/jnen/60.4.369

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  17 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.

Authors:  Sabrina Mosaheb; Julian R Thorpe; Lida Hashemzadeh-Bonehi; Eileen H Bigio; Marla Gearing; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2005-07-16       Impact factor: 17.088

3.  Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.

Authors:  Andreia Neves-Carvalho; Elsa Logarinho; Ana Freitas; Sara Duarte-Silva; Maria do Carmo Costa; Anabela Silva-Fernandes; Margarida Martins; Sofia Cravino Serra; André T Lopes; Henry L Paulson; Peter Heutink; João B Relvas; Patrícia Maciel
Journal:  Hum Mol Genet       Date:  2014-08-20       Impact factor: 6.150

4.  Optineurin immunoreactivity in neuronal and glial intranuclear inclusions in adult-onset neuronal intranuclear inclusion disease.

Authors:  Masataka Nakamura; Melissa E Murray; Wen-Lang Lin; Hirofumi Kusaka; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

5.  Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.

Authors:  U Nagaoka; T Uchihara; K Iwabuchi; H Konno; M Tobita; N Funata; S Yagishita; T Kato
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

6.  Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.

Authors:  Kathryn McFadden; Ronald L Hamilton; Sam J Insalaco; Lawrence Lavine; Majeed Al-Mateen; Guoji Wang; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2005-06       Impact factor: 3.685

7.  Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.

Authors:  Kathryn M Donaldson; Wei Li; Keith A Ching; Serge Batalov; Chih-Cheng Tsai; Claudio A P Joazeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

8.  The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.

Authors:  Brett J Winborn; Sue M Travis; Sokol V Todi; K Matthew Scaglione; Ping Xu; Aislinn J Williams; Robert E Cohen; Junmin Peng; Henry L Paulson
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

9.  Cognitive profiles in adult-onset neuronal intranuclear inclusion disease: a case series from the memory clinic.

Authors:  Fen Wang; Xiaowei Ma; Yuqing Shi; Longfei Jia; Xiumei Zuo; Yueyi Yu; Hongmei Jin; Yi Tang; Dongmei Guo; Jianping Jia
Journal:  Neurol Sci       Date:  2020-11-02       Impact factor: 3.307

10.  Visceral neuropathy and intestinal pseudo-obstruction in a murine model of a nuclear inclusion disease.

Authors:  Christine M Clarke; Cara Plata; Bonnie Cole; Karen Tsuchiya; Albert R La Spada; Raj P Kapur
Journal:  Gastroenterology       Date:  2007-08-21       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.